Trump's team has developed a way to make abortion difficult to obtain without the same costs as an unpopular ban.

Trump won’t back a national abortion ban, but anti-abortion groups have other ideas on how to severely limit access to the ...

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency.

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

West Virginia enacted a law prohibiting abortion in most circumstances shortly following the Dobbs decision in 2022.